Andrew J. Einhorn

Insider Reports History

Location
Durham, NC
Signature
/s/ Andrew J. Einhorn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew J. Einhorn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pelthos Therapeutics Inc. Director Common Stock 12,000 $342,000 $28.50 23 Dec 2025 Direct
RVL Pharmaceuticals plc Chief Financial Officer Ordinary Shares 141,473 $4,414 $0.0312 24 Jan 2022 Direct
RVL Pharmaceuticals plc Chief Financial Officer Ordinary Shares 22,852 $713 $0.0312 24 Jan 2022 By family limited liability company
Osmotica Pharmaceuticals plc Chief Financial Officer Share Option (Right to Buy) 249,814 04 Nov 2021 Direct

Insider Reports Filed by Andrew J. Einhorn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CHRO Pelthos Therapeutics Inc. 23 Dec 2025 1 $0 4 Director 29 Dec 2025, 16:16
CHRO Pelthos Therapeutics Inc. 23 Dec 2025 0 $0 3 Director 29 Dec 2025, 16:15
CGTX COGNITION THERAPEUTICS INC 12 Aug 2022 0 $0 3 Interim CFO 15 Aug 2022, 16:07
/report/000110465922007844-einhorn-andrew-j-2022-01-24 RVL Pharmaceuticals plc 24 Jan 2022 1 -$10,856 4 Chief Financial Officer 26 Jan 2022, 15:31
/report/000110465921135637-einhorn-andrew-j-2021-11-04 Osmotica Pharmaceuticals plc 04 Nov 2021 1 $0 4 Chief Financial Officer 08 Nov 2021, 15:06
/report/000110465921069879-einhorn-andrew-j-2021-05-18 Osmotica Pharmaceuticals plc 18 May 2021 1 -$20,177 4 Chief Financial Officer 20 May 2021, 16:06